CAS: 1443530-05-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Rogaratinib REF: 3D-THC53005CAS: 1443530-05-9 | Min. 95% | 250,00 €~1.796,00 € | Lun 07 Abr 25 |
 | Rogaratinib REF: TM-T16781CAS: 1443530-05-9 | 99.54% | 146,00 €~1.734,00 € | Jue 15 May 25 |
Rogaratinib
CAS:1443530-05-9
Rogaratinib is a kinase inhibitor drug that is used to treat hyperproliferative disease, such as …
Fórmula:
C23H26N6O3S
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
466.56 g/mol
Ref: 3D-THC53005
| 1mg | 250,00 € | ||
| 2mg | 375,00 € | ||
| 5mg | 668,00 € | ||
| 10mg | 954,00 € | ||
| 25mg | 1.796,00 € |
Entrega estimada en Estados Unidos, el Lunes 7 de Abril de 2025
Rogaratinib
CAS:1443530-05-9
Rogaratinib (BAY1163877) is an aberrant inhibitor of fibroblast growth factor receptor (FGFR).
Fórmula:
C23H26N6O3S
Pureza:
99.54%
Forma y color:
Solid
Peso molecular:
466.56
Ref: TM-T16781
| 1mg | 146,00 € |
Entrega estimada en Estados Unidos, el Jueves 15 de Mayo de 2025
